They Survived Cancer—Their Wallets May Not

Cancer patients have better chances of survival than ever—but managing cancer as a chronic illness can bring a lifetime of “financial toxicity.”
 
Breast cancer is the costliest malignancy, with medical costs slated to reach $16.5 billion in the US this year.
 
For individuals, that can mean thousands in extra costs annually—and for the underinsured, choosing between treatment and basic needs.
 
Take lymphodema—a common side effect of cancer treatment that commands $2,306 a year on average in out-of-pocket costs, compared to $1,090 for patients without the condition.

For women lucky enough to survive decades, the expenses are endless.
 
Forbes

Comments +

0 comments

Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top